Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01343004 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women
A Phase 3 study, sponsored by Radius Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,463
- Enrollment target
NCT01343004: Completed Phase 3 study, sponsored by Radius Health.
NCT01343004 is a Phase 3 study that has completed, run by Radius Health. The registered enrollment target is 2,463 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (219% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01343004, a Phase 3 study, has completed, sponsored by Radius Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,463 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether BA058 (abaloparatide), a parathyroid hormone-related peptide, is effective in preventing fractures in postmenopausal women with severe osteoporosis who are at risk of fractures.
Interventions
- DRUG Placebo
- DRUG teriparatide
- DRUG BA058 80 mcg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,463 participants |
| Start Date | 2011-04 |
| Est. Completion | 2014-10 |
| Phase | Phase 3 |
What the finished NCT01343004 record still lists
NCT01343004 is an interventional study that assigns participants to a tested intervention. Its 2,463 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (219% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01343004 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01343004 about?
NCT01343004 is a clinical study titled "Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women". The purpose of this study is to determine whether BA058 (abaloparatide), a parathyroid hormone-related peptide, is effective in preventing fractures in postmenopausal women with severe osteoporosis who are at risk of fractures.
What is the current status of trial NCT01343004?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,463 participants. The study started on 2011-04. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01343004?
The interventions under investigation include: Placebo (DRUG), teriparatide (DRUG), BA058 80 mcg (DRUG).
Who is sponsoring clinical trial NCT01343004?
This trial is sponsored by Radius Health, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01343004's enrollment target sits among peer trials
2,463 88th of 2000 higher than 1,913 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06898593 · 2,448 participants · NA
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
- NCT06128304 · 2,436 participants · NA
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
- NCT06676904 · 2,433 participants · NA
Neonatal Platelet Transfusion Threshold Trial
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia